Humacyte, Inc. (HUMA) Earnings
Humacyte, Inc.'s most recently reported earnings, recent earnings filings (8-K) and headline annual financials, sourced from SEC EDGAR.
Last reported earnings
Aug 12, 2026
From the latest earnings 8-K
Revenue • FY2025
$2.04M
As reported
Diluted EPS • FY2025
-$0.26
▲ 79.4%YoY
Reported earnings dates are based on the latest 8-K (Item 2.02) filings. The next earnings date is an estimate projected from HUMA's historical reporting pattern, not a company-confirmed date.
Headline financials
| Period | Revenue | Net income | Gross profit | Dil. EPS | Free cash flow | Op. margin | Rev. growth |
|---|---|---|---|---|---|---|---|
| FY2025 | $2.04M | -$40.83M | -$7.66M | -$0.26 | -$105.93M | -5306.0% | — |
| FY2024 | $0 | -$148.7M | — | -$1.26 | -$99.69M | — | — |
| FY2023 | $0 | -$110.78M | — | -$1.07 | -$75.58M | — | — |
| FY2022 | $0 | -$11.96M | — | -$0.12 | -$72.18M | — | — |
Recent earnings filings
| Filed | Form | Accession |
|---|---|---|
| Aug 12, 2026 | 8-K (2.02) | 0001104659-26-094440EDGAR |
| Mar 19, 2026 | 8-K (2.02) | 0001104659-26-031780EDGAR |
| Nov 12, 2025 | 8-K (2.02) | 0001104659-25-109718EDGAR |
| Aug 11, 2025 | 8-K (2.02) | 0001818382-25-000122EDGAR |
| May 13, 2025 | 8-K (2.02) | 0001818382-25-000073EDGAR |
| Mar 28, 2025 | 8-K (2.02) | 0001818382-25-000030EDGAR |
| Nov 8, 2024 | 8-K (2.02) | 0001818382-24-000197EDGAR |
| Aug 13, 2024 | 8-K (2.02) | 0001818382-24-000153EDGAR |
Never miss a HUMA filing.
Get an email when HUMA files its next 8-K, Form 4, 10-K or 10-Q with the SEC. Free, no account needed.
Free foreverNo account requiredOne-click unsubscribe
Data as of Nov 8, 2026Source: SEC EDGAR.